Deaths and disability from natalizumab are no longer tolerable: No - (they can be avoided)

2 Citationer (Scopus)
OriginalsprogEngelsk
TidsskriftMultiple Sclerosis
Vol/bind18
Udgave nummer8
Sider (fra-til)1070-2
Antal sider3
ISSN1352-4585
DOI
StatusUdgivet - aug. 2012

Citationsformater